<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC7090728/results/search/medproc/results.xml">
  <result pre="fever (50%) and cough (38%). All patients recovered with symptomatic" exact="therapy" post="and there were no deaths. One case of severe"/>
  <result pre="extra corporeal membrane oxygen support may be needed. Renal replacement" exact="therapy" post="may be needed in some. Antibiotics and antifungals are"/>
  <result pre="advocate against their use, Chinese guidelines do recommend short term" exact="therapy" post="with low-to-moderate dose corticosteroids in COVID-19 ARDS [ 24,"/>
  <result pre="4%, extracorporeal membrane oxygenation (ECMO) in 3%, continuous renal replacement" exact="therapy" post="(CRRT) in 9%, antibiotics in 71%, antifungals in 15%,"/>
  <result pre="71%, antifungals in 15%, glucocorticoids in 19% and intravenous immunoglobulin" exact="therapy" post="in 27% [ 15]. Antiviral therapy consisting of oseltamivir,"/>
  <result pre="19% and intravenous immunoglobulin therapy in 27% [ 15]. Antiviral" exact="therapy" post="consisting of oseltamivir, ganciclovir and lopinavir-ritonavir was given to"/>
  <result pre="needed before these drugs are recommended. Other drugs proposed for" exact="therapy" post="are arbidol (an antiviral drug available in Russia and"/>
 </snippets>
</snippetsTree>
